Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated mRNA Transport02:22

Regulated mRNA Transport

3.5K
3.5K
Regulated mRNA Transport02:22

Regulated mRNA Transport

7.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.3K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

3.7K
3.7K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

6.8K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
6.8K
Nucleic Acid Structure01:25

Nucleic Acid Structure

10.3K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
10.3K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

9.3K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipah virus destroyed my personal, family, and social life: stories of the hardship faced by Nipah survivors in Bangladesh.

International journal for equity in health·2026
Same author

Empowering youth: a school-based digital awareness campaign for sustainable Nipah virus prevention in Bangladesh.

IJID regions·2026
Same author

A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

Nature communications·2026
Same author

Proteomic landscape of colorectal cancer liver metastasis: molecular signatures and novel therapeutic targets.

PeerJ·2026
Same author

CCL24 recruits CCR3<sup>+</sup> TAMs to promote immunosuppression via YAP1 activation and serves as a therapeutic target for Gracillin in colorectal cancer.

International journal of biological sciences·2026
Same author

Association Between Lifestyle and Dietary Habits With C-Reactive Protein and Glucose: A Cross-Sectional Study.

Health science reports·2026
Same journal

Host-directed antimicrobial peptide biomaterials for combating Gram-negative bacterial infections.

Biomaterials science·2026
Same journal

TRPV-1-targeted Fe-phenolate network provokes apoptosis and ferroptosis to treat non-small cell lung cancer.

Biomaterials science·2026
Same journal

Effect of titanium-based anisotropic magnetic hydrogel coating on osseointegration.

Biomaterials science·2026
Same journal

Stable, micron-scale lipocondensates achieving prolonged circulation without PEGlyated lipids.

Biomaterials science·2026
Same journal

Fiber and continuum scale contributions to the intrinsic and apparent fracture of soft collagenous tissue <i>via</i> cutting.

Biomaterials science·2026
Same journal

Surface morphology-regulated tissue adhesion in solid and mesoporous silica-reinforced gelatin nanocomposite hydrogels.

Biomaterials science·2026
See all related articles

Related Experiment Video

Updated: Apr 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.7K

Biomaterials for mRNA delivery.

Mohammad Ariful Islam1, Emma K G Reesor, Yingjie Xu

  • 1Laboratory for Nanoengineering & Drug Delivery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jinjun.shi@zeus.bwh.harvard.edu.

Biomaterials Science
|August 18, 2015
PubMed
Summary
This summary is machine-generated.

Messenger RNA (mRNA) offers advantages over DNA therapies but faces delivery challenges. Advanced biomaterials and nanotechnology are crucial for overcoming these hurdles and enabling mRNA therapeutics.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.7K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.8K

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Messenger RNA (mRNA) presents a promising alternative to DNA-based therapies due to its unique advantages.
  • mRNA therapies avoid nuclear entry and genomic integration, mitigating risks of harmful genetic alterations.
  • Chemical modifications enhance mRNA stability and reduce innate immune responses, while rapid expression and predictable kinetics are beneficial.

Purpose of the Study:

  • To provide an overview of current biomaterials and nanotechnology for mRNA delivery.
  • To discuss the challenges and future prospects of mRNA therapeutic development.

Main Methods:

  • Review of state-of-the-art biomaterials for mRNA delivery.
  • Analysis of nanotechnology platforms enabling mRNA transfection.
  • Discussion of mRNA characteristics impacting therapeutic applications.

Main Results:

  • mRNA offers advantages like no nuclear entry and no genomic integration.
  • Chemical modifications improve mRNA stability and reduce immunogenicity.
  • Challenges include mRNA's size, charge, and susceptibility to degradation.

Conclusions:

  • Refined mRNA delivery systems are essential for therapeutic development.
  • Biomaterials and nanotechnology are key to overcoming current mRNA limitations.
  • Future prospects involve translating these advanced delivery technologies into clinical practice.